VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection

NCT05364242 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
178
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Valneva Austria GmbH